The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Prediction of acute myeloid leukaemia risk in healthy individuals
Open accessAbstract
The incidence of acute myeloid leukaemia (AML) increases with age and mortality exceeds 90% when diagnosed after age 65. Most cases arise without any detectable early symptoms and patients usually present with the acute complications of bone marrow failure 1. The onset of such de novo AML cases is typically preceded by the accumulation of somatic mutations in preleukaemic haematopoietic stem and progenitor cells (HSPCs) that undergo clonal expansion 2,3. However, recurrent AML mutations also accumulate in HSPCs during ageing of healthy individuals who do not develop AML, a phenomenon referred to as age-related clonal haematopoiesis (ARCH)4-8. Here we use deep sequencing to analyse genes that are recurrently mutated in AML to distinguish between individuals who have a high risk of developing AML and those with benign ARCH. We analysed peripheral blood cells from 95 individuals that were obtained on average 6.3 years before AML diagnosis (pre-AML group), together with 414 unselected age- and gender-matched individuals (control group). Pre-AML cases were distinct from controls and had more mutations per sample, higher variant allele frequencies, indicating greater clonal expansion, and showed enrichment of mutations in specific genes. Genetic parameters were used to derive a model that accurately predicted AML-free survival; this model was validated in an independent cohort of 29 pre-AML cases and 262 controls. Because AML is rare, we also developed an AML predictive model using a large electronic health record database that identified individuals at greater risk. Collectively our findings provide proof-of-concept that it is possible to discriminate ARCH from pre-AML many years before malignant transformation. This could in future enable earlier detection and monitoring, and may help to inform intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, progression to hematological malignancies depends on the type and complexity of mutations in CHIP.2,5,6”
From Aging drives Tet2 +/− clonal hematopoiesis via IL-1 signaling (2023) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CH-associated variants of the epigenetic writers and erasers Dnmt3a and Tet2, respectively, that affect the HSPC methylome have been shown to alter functions of monocyte-derived tissue M F and promote cardiovascular pathologies 31-34 .”
From Clonal hematopoiesis-associated motoric deficits caused by monocyte-derived microglia accumulating in aging mice (2025) · cites this paper as [34]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CH prominently involves variants of epigenetic regulatory genes, such as DNMT3A and TET2, which constitute an increased risk for hematologic malignancies, cardiovascular events and stroke 34,45,70,71 .”
From Clonal hematopoiesis-associated motoric deficits caused by monocyte-derived microglia accumulating in aging mice (2025) · cites this paper as [34]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Clone size, which is approximated by the variant allele fraction (VAF), has previously been shown to be an important predictor of risk for blood cancer1,17 and cardiovascular outcomes8,9.”
From Clonal hematopoiesis is associated with protection from Alzheimer’s disease (2023) · cites this paper as [17]
The cited source says what the claim attributes to it.
In the citing paper
“CH prominently involves variants of epigenetic regulatory genes, such as DNMT3A and TET2, which constitute an increased risk for hematologic malignancies, cardiovascular events and stroke 34,45,70,71 .”
From Clonal hematopoiesis-associated motoric deficits caused by monocyte-derived microglia accumulating in aging mice (2025) · cites this paper as [34]
In the citing paper
“Both groups found that individuals with antecedent clonal hematopoiesis were at ~3 to 5-fold increased risk for developing AML in the subsequent years (Fig. 3A).”
From Clonal hematopoiesis in human aging and disease (2019) · cites this paper as [71]
In the citing paper
“The effect of specific gene variants on various outcomes may be quite different, as has been found in AML 71.”
From Clonal hematopoiesis in human aging and disease (2019) · cites this paper as [71]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M., et al. (2010) · Genome Research · doi:10.1101/gr.107524.110 · Cited by 27,895
BEDTools: a flexible suite of utilities for comparing genomic features
Quinlan, A. R., & Hall, I. M. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq033 · Cited by 27,437
Fast and accurate long-read alignment with Burrows-Wheeler transform.
Li, H., & Durbin, R. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp698 · Cited by 12,063
Arber, D. A., Orazi, A., Hasserjian, R., Thiele, J., Borowitz, M. J., Le Beau, M. M., Bloomfield, C. D., Cazzola, M., & Vardiman, J. W. (2016) · Blood · doi:10.1182/blood-2016-03-643544 · Cited by 10,119
Modeling Survival Data: Extending the Cox Model
Therneau, T. M., & Grambsch, P. M. (2000) · Statistics for Biology and Health · doi:10.1007/978-1-4757-3294-8 · Cited by 8,674
VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencingPreprint
Koboldt, D. C., Zhang, Q., Larson, D. E., Shen, D., McLellan, M. D., Lin, L., Miller, C. A., Mardis, E. R., Ding, L., & Wilson, R. K. (2012) · Genome Research · doi:10.1101/gr.129684.111 · Cited by 4,954
Age-related clonal hematopoiesis associated with adverse outcomes
Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P. V., Mar, B. G., Lindsley, R. C., Mermel, C. H., Burtt, N., Chavez, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408617 · Cited by 4,841
Genomic classification and prognosis in acute myeloid leukemia
Papaemmanuil, E., Gerstung, M., Bullinger, L., Gaidzik, V. I., Paschka, P., Roberts, N. D., Potter, N. E., Heuser, M., Thol, F., Bolli, N., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1516192 · Cited by 4,350
Self-citationClonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence
Genovese, G., Kähler, A. K., Handsaker, R. E., Lindberg, J., Rose, S. A., Bakhoum, S. F., Chambert, K., Mick, E., Neale, B. M., Fromer, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409405 · Cited by 3,531
Cited by
Sorted by citations
Items 701–800 of 847
Zhu, H. J., Yang, B., Liu, J., Wang, B., Wu, Y., Zheng, Z., & Ling, Y. (2021) · Therapeutic Advances in Hematology · doi:10.1177/20406207211009334 · Cited by 1
KOÇYİĞİT, H., & Karagözoğlu, Ş. (2021) · Ege Üniversitesi Hemşirelik Fakültesi Dergisi · doi:10.53490/egehemsire.857874 · Cited by 1
Yin, Y., Jiang, R., Shen, M., Li, Z., Yan, N., Feng, J., Jiang, H., Lv, J., Shi, L., Wang, L., et al. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03268-z · Cited by 1
Einfluss der klonalen Hämatopoese auf nicht-hämatologische Erkrankungen und Alterungsprozesse
Rieger, M. A. (2022) · Die Innere Medizin · doi:10.1007/s00108-022-01409-6 · Cited by 1
Management of Newly Diagnosed Acute Myeloid Leukemia in Older Adults
Gupta, G., & Garg, V. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.109700 · Cited by 1
Haferlach, C., & Haferlach, T. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy499 · Cited by 1
Sperling, A. S., & Ebert, B. L. (2019) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djz158 · Cited by 1
Clonal Hematopoiesis Leading to AITL and NPM1 -Mutated AML
Tiacci, E., & Falini, B. (2018) · New England Journal of Medicine · doi:10.1056/nejmc1813168 · Cited by 1
Schuettpelz, L. G. (2021) · Blood · doi:10.1182/blood.2021012877 · Cited by 1
The Journey to Clonal Hematopoiesis and Applications Incardiovascular Disease and CancerPreprint
Redondo, S., & de Oteyza, J. P. (2023) · Preprints.org · doi:10.20944/preprints202310.1750.v1 · Cited by 1
Natural and age-related variation in circulating human hematopoietic stem cellsPreprint
Furer, N., Rappoport, N., Milman, O., Lifshitz, A., Bercovich, A., Ben-Kiki, O., Danin, A., Kedmi, M., Shipony, Z., Lipson, D., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.30.569167 · Cited by 2
Chow, R. D.-W., Velu, P., Deihimi, S., Belman, J., Youn, A., Shah, N., Luger, S. M., Carroll, M. P., Morrissette, J. D., & Bowman, R. L. (2024) · medRxiv · doi:10.1101/2024.08.31.24312756 · Cited by 1
Risk of Clonal Hematopoiesis of Indeterminate Potential after Cancer Radiation TherapyPreprint
Crants, S., Olson, S. S., Li, Y., Bejan, C. A., Vlasschaert, C., Mack, T. M., Pershad, Y., Kishtagari, A., Reed, S. C., Croessmann, S., et al. (2024) · medRxiv · doi:10.1101/2024.09.27.24314321 · Cited by 1
Methylation dynamics in the decades preceding acute myeloid leukaemiaPreprint
Fonseca, A. V. A., Boniface, C. T., Watson, C. J., Hackett, S., Gabbutt, C., Ramos-Yamasaki, A. D., Tan, A. B., Montoya, J., Strogantsev, R., Hanssen, L. E., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.26.661643 · Cited by 1
Scheer, F. (2026) · Research Square · doi:10.21203/rs.3.rs-10397076/v1 · Cited by 1
Fei, D. L., Zhen, T., Durham, B., Ferrarone, J., Zhang, T., Garrett, L., Yoshimi, A., Abdel-Wahab, O., Bradley, R. K., Liu, P., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/345538
Romero, D. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0078-z
Dart, A. (2018) · Nature Reviews Genetics · doi:10.1038/s41576-018-0041-y
Médecine génomique en oncologie : état de l’art et défis à relever
Callanan, M. B., & Ghiringhelli, F. (2018) · Revue Francophone des Laboratoires · doi:10.1016/s1773-035x(18)30319-8
Temporal inhibition of autophagy reveals segmental reversal of aging with increased cancer riskPreprint
Cassidy, L. D., Young, A. R. J., Young, C., Soilleux, E. J., Fielder, E., Weigand, B. M., Brais, R. J., Wiggins, K. A., Clarke, M. C. H., Jurk, D., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/528984
Myeloid malignancies‐related somatic mutations in aging individuals
Coutinho, D. F., Zalcberg, I. R., & Monte-Mór, B. D. C. R. (2019) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.683
Função mitocondrial em camundongos e pacientes com defeitos em componentes da biologia dos telômeros
Santos, A. L. P. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2019.tde-12022019-110525
Berger, M. G., & Bourgne, C. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-14366-4_10
Relationship between disease biology and clinical phenotype in myeloproliferative neoplasms
Nangalia, J. (2019) · HemaSphere · doi:10.1097/hs9.0000000000000207
Haase, D. T. (2019) · best practice onkologie · doi:10.1007/s11654-019-00167-6
Molecular diagnostics and risk assessment in myeloid malignancies
Scharenberg, C., & Haferlach, T. (2019) · doi:10.1002/9781119252863.ch4
Feldman, T., Bercovich, A., Moskovitz, Y., Chapal-Ilani, N., Mitchell, A., Medeiros, J. J. F., Kaushansky, N., Biezuner, T., Minden, M. D., Gupta, V. K., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.01.01.888610
Physiologic and pathologic profiling of clonal variations
Wong, W. (2019) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/scfg-zs49
Young and Restless: Expansion of Donor-Origin Mutant HSCs after Transplantation
Steensma, D. P. (2020) · Cell stem cell · doi:10.1016/j.stem.2020.01.022
MDS Mimics Including CHIP, ICUS, and CCUS
Bejar, R. L. (2020) · Springer eBooks · doi:10.1007/978-3-030-51878-3_6
Dezern, A. E., & Marple, A. (2020) · The Hematologist · doi:10.1182/hem.v17.3.10321
Deciphering the Dilemmas Posed by Detection of Mutant Myeloid Clones
Roberts, A. W. (2018) · The Hematologist · doi:10.1182/hem.v16.1.9299
A meghatározatlan jelentőségű klonális hemopoesis (CHIP) aktuális kérdései – irodalmi áttekintés
Jakó, J., & Szerafin, L. (2020) · Hematológia–Transzfuziológia · doi:10.1556/2068.2020.53.2.7
ASXL1 Directs Neutrophilic Differentiation via Modulation of MYC and RNA Polymerase IIPreprint
Braun, T. P., Estabrook, J., Darmusey, L., Coleman, D. J., Schonrock, Z., Smith, B. M., Taherinasab, A., Enright, T., Coblentz, C., Yashar, W. M., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.09.14.295295
[Global research hotspots on oncology-bibliometric analysis based on the ESI hot papers].
Han, X., Li, X., Gong, X., Li, B., Bai, B., Zhang, L., Pu, J. Y., Li, Y., & Zhang, M. (2020) · PubMed · doi:10.7507/1001-5515.202009083
Coster, D., Fisher, E., Shenhar‐Tsarfaty, S., Menes, T. S., Berliner, S., Rogowski, O., Zeltser, D., Shapira, I., Halperin, E., Rosset, S., et al. (2021) · medRxiv · doi:10.1101/2021.01.11.21249491
A view from the hospital window.
Richards, A. G. (1974) · PubMed
Yin, Y., Jiang, R., Shen, M., Li, Z., Yan, N., Feng, J., Jiang, H., Lv, J., Shi, L., Wang, L., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.09.430530
The Role of the Microbiome in Cancer and the Development of Cancer Therapeutics.
Belknap, K. C., Cote, A. L., McGill, C. M., Andam, C. P., & Barth, B. M. (2020) · PubMed
Identifying Novel Genomic Variants in Hemophagocytic Lymphohistiocytosis in Adults
Ceremsak, J. J. (2021) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Franco, O. A., & Morales, N. O. (2021) · Revista Colombiana de Cancerología · doi:10.35509/01239015.726
Acute Myeloid Leukaemia with inv (16) in a 2-year-old Boy: A Diagnostic Dilemma
Haidary, A. M., Malakzai, H. A., Khairy, A. L., Hashimi, S. A., Saadaat, R., Haidari, M., Abdul‐Ghafar, J., Rasooli, A. J., Noor, S., Noor, S., et al. (2021) · Journal of Clinical Haematology · doi:10.33696/haematology.2.037
Socastro, S. A. (1988) · Revista de la Universidad Complutense
Huang, R., Liao, X., & Li, Q. (2020) · Research Square · doi:10.21203/rs.3.rs-47484/v1
Galassi, L., Colasante, C., Bettelli, F., Gilioli, A., Pioli, V., Giusti, D., Morselli, M., Paolini, A., Nasillo, V., Lusenti, B., et al. (2021) · Leukemia Research · doi:10.1016/j.leukres.2021.106747
A simple procedure for endotracheal intubation of the dog. (a photo essay).
Brown, C. M., & Bridge, L. A. (1979) · PubMed
Vainchenker, W., & Plo, I. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.738193794.793578394
Coster, D., Fisher, E., Shenhar‐Tsarfaty, S., Menes, T. S., Berliner, S. A., Rogowski, O., Zeltser, D., Shapira, I., Halperin, E., Rosset, S., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1298640/v1
Clonal Hematopoiesis and Hematological Disorders
Makishima, H. (2021) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.110.301
Rock inhibitors target SRSF2 leukemia by disrupting cell mitosis and nuclear morphologyPreprint
Su, M., Fleisher, T. A., Grosheva, I., Horev, M. B., Olszewska, M., Barr, H. M., Plotnikov, A. N., Carvalho, S., Moskovich, Y., Minden, M., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.02.15.479934
Pathogenese und molekulare Diagnostik der akuten myeloischen Leukämie
Krämer, A., & Thiede, C. (2022) · Die Onkologie · doi:10.1007/s00761-022-01183-y
Deepak Shyl, E. S., Beutline Malgija, M., Iniyan, A. M., & Vincent, S. G. P. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4073436
Active Learning for Microarray based Leukemia Classification
Zhu, K. (2021) · International Conference on Biomedical and Bioinformatics Engineering (ICBBE) · doi:10.1145/3502871.3502884
Kaufman, D. S. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.737215426.793570098
Deng, Z., Su, X., Zhu, X., Zhao, Q., Ke, J.-M., Wu, D.-L., Yi, Y., Yi, J., Jiang, L., Qian, J., et al. (2020) · doi:10.21203/rs.3.rs-25574/v2
Vainchenker, W., & Constantinescu, S. N. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.736388510.793565257
Deng, Z., Su, X., Zhu, X., Zhao, Q., Ke, J.-M., Wu, D.-L., Yi, Y., Yi, J., Jiang, L., & Qian, J. (2020) · doi:10.21203/rs.3.rs-25574/v1
Klonale Hämatopoese – Verbindungsglied kardiovaskulärer und hämatologischer Erkrankungen
Frick, M., & Damm, F. (2022) · Transfusionsmedizin · doi:10.1055/a-1720-8217
Klonale Hämatopoese – Ursachen und klinische Implikationen
Burchert, A. (2022) · Die Innere Medizin · doi:10.1007/s00108-022-01388-8
Clonal Hematopoiesis in Cancer
Rauch, P. J., & Steensma, D. P. (2022) · Wiley eBooks · doi:10.1002/9781119000822.hfcm145
Cellular heterogeneity and clonal hematopoiesis of immune system cells in atherosclerosis
Слепцов, А. А. (2022) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2022-5228
Mtashar, B. A., Ashoor, Z. F., Shabeeb, Z. A., & Matti, B. F. (2022) · Journal of Pharmaceutical Negative Results · doi:10.47750/pnr.2022.13.s05.21
Mtashar, B. A., Ashoor, Z. F., Shabeeb, Z., & Matti, B. F. (2022) · Mustansiriya Medical Journal · doi:10.4103/mj.mj_29_22
Spitzer, B. G., Rutherford, K. D., Gundem, G., McGovern, E. M., Millard, N. E., Ossa, J. A., Cheung, I. Y., Gao, T., Levine, M. F., Zhang, Y., et al. (2023) · doi:10.1158/1078-0432.c.6530798
Kim, R., Bergugnat, H., Larcher, L., Duchmann, M., Passet, M., Gachet, S., Cuccuini, W., Lafage‐Pochitaloff, M., Pastoret, C., Grardel, N., et al. (2023) · doi:10.1158/2643-3230.c.6551136.v1
Accelerated Clonal Hematopoiesis in Pediatric and Young Adult Survivors of Childhood CancerPreprint
Greer, C. D., Kroger, B. R., Hartshorne, T., Xu, J., Chung, S. S., & Dickerson, K. E. (2023) · medRxiv · doi:10.1101/2023.05.03.23289475
Spectrum From Clonal Hematopoiesis to Myelodysplastic Neoplasm/Syndromes and Other Myeloid Neoplasms
Xie, Z., Chen, E. C., Mendez, L., Komrokji, R. S., & Zeidan, A. M. (2023) · The Cancer Journal · doi:10.1097/ppo.0000000000000656
EXABS-171-MDS Update on CHIP and CCUS
Weeks, L. D. (2023) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/s2152-2650(23)00310-5
Cell of origin epigenetic priming determines susceptibility to Tet2 mutationPreprint
Schiroli, G., Kartha, V. K., Duarte, F. M., Kristiansen, T. A., Mayerhofer, C., Shrestha, R., Earl, A., Hu, Y., Tay, T., Rhee, C., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.04.556230
Neuendorff, N. R., Bittner, A., Flossdorf, S., Mauer, T., Schmitz, F., Neuhoff, N. V., Köster, J., Mölder, F., Schneider, M., Turki, A. T., et al. (2023) · Ageing and Cancer Research & Treatment · doi:10.37155/2972-4759-2023-01-01-4 · Cited by 1
Bryukhovetskiy, A. S., Grivtsova, L. Y., Bogachev, S. S., Ustyugov, A. A., Nebogatikov, V. O., & Shurdov, M. A. (2023) · International review of neurobiology · doi:10.1016/bs.irn.2023.07.005
Molecular Techniques in the Diagnosis and Monitoring of Acute and Chronic Leukaemias
Ip, H., & Tang, W. (2023) · Springer eBooks · doi:10.1007/978-981-99-3810-0_3
Impact of clonal hematopoiesis in COVID-19 patients at high risk for adverse clinical outcomes
Smith, C., Burugula, B. B., Jones, M. A., Li, Q., Kitzman, J. O., & Wong, T. (2023) · Translational Medicine Communications · doi:10.1186/s41231-023-00155-7
Evolution of clonal hematopoiesis
van Zeventer, I. A., de Graaf, A. O., Jansen, J. H., & Huls, G. A. (2023) · Clinical and Translational Medicine · doi:10.1002/ctm2.1444
ASSOCIATION OF RAS GENE EXPRESSION WITH NPM1 MUTATION IN ACUTE MYELOID LEUKEMIA PAKISTANI PATIENTS
Rukhsar, A., Tayyab, M. H., Ahmed, A., Zahid, S., Ashfaq, H., Naeem, S., Ali, M. A., Sargana, N. I., Malik, L., Malik, A., et al. (2023) · doi:10.53555/jptcp.v30i18.3256
Wang, L. L., & Chen, S. N. (2023) · PubMed Central · doi:10.3760/cma.j.issn.0253-2727.2023.10.009
The Origin of Clonal Hematopoiesis and Its Implication in Human Diseases
Zhang, Z., & Sun, J. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-99-7471-9_5
Coster, D., Fisher, E., Shenhar‐Tsarfaty, S., Menes, T. S., Berliner, S. A., Rogowski, O., Zeltser, D., Shapira, I., Halperin, E., Rosset, S., et al. (2024) · Proceedings of the AAAI Symposium Series · doi:10.1609/aaaiss.v2i1.27711
Prognostic Role and Clinical Utility of Measurable Residual Disease in Acute Myeloid Leukemia
Odetola, O. E., & Abaza, Y. (2024) · Advances in Oncology · doi:10.1016/j.yao.2024.02.004
Molecular diagnostics and risk assessment in myeloid malignancies
Scharenberg, C., & Haferlach, T. (2024) · doi:10.1002/9781394180486.ch4
Seo, J., Lee, C., Koh, Y., Sun, C. H., Lee, J.-M., An, H., & Kim, M. (2024) · Leukemia Research Reports · doi:10.1016/j.lrr.2024.100419
Uddin, M. M., Zhou, Y., Bick, A. G., Burugula, B. B., Jaiswal, S., Desai, P. M., Honigberg, M. C., Love, S.-A. M., Barac, A., Hayden, K. M., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19862534
Wang, Z., Zhang, Y., Fu, T., Chen, L., Li, K., Xu, L., Sun, Y., & Kong, F. (2024) · Research Square · doi:10.21203/rs.3.rs-4268241/v1
Tian, S., Jenkinson, G., Ferrer, A., Yan, H., Morales‐Rosado, J. A., Wang, K. L., Lasho, T. L., Yan, B. B., Baheti, S., Olson, J. E., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.22.590586
Mimicry of inherited red cell disorders: the result of somatic mutations in a clonal myeloid disease
Lichtman, M. A., & Jajosky, A. N. (2024) · Haematologica · doi:10.3324/haematol.2024.286211
The Clonal Hematopoiesis-associated Gene Srcap Plays an Essential Role in HematopoiesisPreprint
Wong, T., Mychalowych, A., Feldpausch, E. R., Carson, A., Karpova, D., & Link, D. C. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.16.607812
Müskens, K. F., Wieringa, N., van Bergen, M., Bense, J. E., Pas, B. M. T., de Pagter, A. P. J., Lankester, A. C., Bierings, M., Neuberg, D. S., Haitjema, S., et al. (2024) · medRxiv · doi:10.1101/2024.09.28.24314531
Dunn, W. G., Withnell, I., Gu, M., Quirós, P. M., Kovilakam, S. C., Marando, L., Wen, S., Fabre, M. A., Mohorianu, I. I., Vuckovic, D., et al. (2024) · medRxiv · doi:10.1101/2024.09.30.24314606
CHIP - Management und klinische Implikationen
Hecker, J. S., Pachzelt, L., Buck, M. C., von Scheidt, M., & Bassermann, F. C. (2024) · InFo Hämatologie + Onkologie · doi:10.1007/s15004-024-0776-x
Aspectos moleculares de las mutaciones TP53 en las neoplasias mieloides
Calasanz, M. J. (2024) · Revista Sangre · doi:10.24875/sangre.m24000018
PHALCON: phylogeny-aware variant calling from large-scale single-cell panel sequencing datasetsPreprint
Priya, Chowdary, S. B. V., Gautam, A., & Zafar, H. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.26.630385
Fabre, M. A., & Vassiliou, G. S. (2025) · Wiley eBooks · doi:10.1002/9781119706687.ch38
Redondo, S. (2025) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.arteri.2025.500767
MYD88 mutations in clonal hematopoiesis promote inflammation and hematopoietic stem cell expansionPreprint
Yeung, J., Philbrook, S. Y., Uible, E. E., Lee, L. H., Choi, K., Agarwal, P., Clough, C. A., Patel, P., Wikenheiser‐Brokamp, K. A., Hueneman, K. M., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.19.660202 · Cited by 1
Differential Tissue Macrophage Ontogeny and its Impact on Physiology
Jung, S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-824465-4.00270-2
Weinstock, J. S., Conneely, K. N., Woo, J., Arvanitis, M., Machiela, M. J., & Russell, C. (2025) · medRxiv · doi:10.1101/2025.10.12.25337792
Geography, Ancestry, Age and Sex Shape Somatic Autosomal Mosaic Chromosomal Alterations in BloodPreprint
Kang, J. R. W., Kim, Y., Skead, K., Soave, D. M., Evans, J., Bruat, V., Harwood, M. P., Morris, Q., Matovu, E., Mulindwa, J., et al. (2025) · medRxiv · doi:10.1101/2025.10.19.25338239
EWSR1 as a candidate prognostic indicator in acute myeloid leukemia
Qian, L., Zhang, P., Chen, T., Chen, Y., Mu, Q., & Zou, D. (2025) · Hematology · doi:10.1080/16078454.2025.2588838
Metadata
- Authors
- Abelson, S., Collord, G., Ng, S. W. K., Weissbrod, O., Mendelson Cohen, N., Niemeyer, E., Barda, N., Zuzarte, P. C., Heisler, L., Sundaravadanam, Y., Luben, R., Hayat, S., Wang, T. T., Zhao, Z., Cirlan, I., Pugh, T. J., Soave, D., Ng, K., Latimer, C., Hardy, C., Raine, K., Jones, D., Hoult, D., Britten, A., McPherson, J. D., Johansson, M., Mbabaali, F., Eagles, J., Miller, J. K., Pasternack, D., Timms, L., Krzyzanowski, P., Awadalla, P., Costa, R., Segal, E., Bratman, S. V., Beer, P., Behjati, S., Martincorena, I., Wang, J. C. Y., Bowles, K. M., Quirós, J. R., Karakatsani, A., La Vecchia, C., Trichopoulou, A., Salamanca-Fernández, E., Huerta, J. M., Barricarte, A., Travis, R. C., Tumino, R., Masala, G., Boeing, H., Panico, S., Kaaks, R., Krämer, A., Sieri, S., Riboli, E., Vineis, P., Foll, M., McKay, J., Polidoro, S., Sala, N., Khaw, K.-T., Vermeulen, R., Campbell, P. J., Papaemmanuil, E., Minden, M. D., Tanay, A., Balicer, R. D., Wareham, N. J., Gerstung, M., Dick, J. E., Brennan, P., Vassiliou, G. S., & Shlush, L. I.
- Affiliations
- University Health Network (CA)
- University of Cambridge (GB)
- University of Toronto (CA)
- Weizmann Institute of Science (IL)
- Clalit Health Services (IL)
- Ontario Institute for Cancer Research (CA)
- Wellcome Sanger Institute (GB)
- Centre international de recherche sur le cancer (FR)
- European Bioinformatics Institute (GB)
- University of East Anglia (GB)
- Gobierno del Principado de Asturias (ES)
- National and Kapodistrian University of Athens (GR)
- Hellenic Health Foundation (GR)
- Instituto Murciano de Investigación Biosanitaria (ES)
- Instituto de Salud Pública de Navarra (ES)
- University of Oxford (GB)
- Istituto per lo Studio e la Prevenzione Oncologica (IT)
- German Institute of Human Nutrition (DE)
- Federico II University Hospital (IT)
- German Cancer Research Center (DE)
- Fondazione IRCCS Istituto Nazionale dei Tumori (IT)
- Imperial College London (GB)
- Italian institute for Genomic Medicine (IT)
- Institut d'Investigació Biomédica de Bellvitge (ES)
- Utrecht University (NL)
- Memorial Sloan Kettering Cancer Center (US)
- World Health Organization (CH)
- Wellcome/MRC Cambridge Stem Cell Institute (GB)
- Corresponding author
- Gerstung, Moritz
- Dick, John E.
- Brennan, Paul
- Vassiliou, George S.
- Shlush, Liran I.
- ORCID
- Abelson, Sagi
- Collord, Grace
- Ng, Stanley W. K.
- Weissbrod, Omer
- Barda, Noam
- Zuzarte, Philip C.
- Heisler, Lawrence
- Sundaravadanam, Yogi
- Luben, Robert
- Hayat, Shabina
- Zhao, Zhen
- Cirlan, Iulia
- Pugh, Trevor J.
- Soave, David
- Ng, Karen
- Latimer, Calli
- Raine, Keiran
- Jones, David
- Britten, Abigail
- McPherson, John D.
- Johansson, Mattias
- Eagles, Jenna
- Miller, Jessica K.
- Krzyzanowski, Paul
- Awadalla, Philip
- Costa, Rui
- Segal, Eran
- Bratman, Scott V.
- Beer, Philip
- Behjati, Sam
- Wang, Jean C. Y.
- Bowles, Kristian M.
- Karakatsani, Anna
- Trichopoulou, Antonia
- Huerta, José M.
- Barricarte, Aurelio
- Travis, Ruth C.
- Tumino, Rosario
- Masala, Giovanna
- Boeing, Heiner
- Panico, Salvatore
- Kaaks, Rudolf
- Krämer, Alwin
- Sieri, Sabina
- Vineis, Paolo
- Foll, Matthieu
- McKay, James
- Polidoro, Silvia
- Sala, Núria
- Khaw, Kay-Tee
- Vermeulen, Roel
- Campbell, Peter J.
- Papaemmanuil, Elli
- Minden, Mark D.
- Tanay, Amos
- Balicer, Ran D.
- Wareham, Nicholas J.
- Gerstung, Moritz
- Dick, John E.
- Brennan, Paul
- Vassiliou, George S.
- Shlush, Liran I.
- Venue
- Nature
- Published
- 2018-07
- Volume
- 559
- Issue
- 7714
- Pages
- 400-404
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC6485381
- OpenAlex
- W2830196912
- Cited by
- 850
- References
- 49
- Citations by year
- 2026: 52 · 2025: 83 · 2024: 95 · 2023: 116 · 2022: 122 · 2021: 116 · 2020: 143 · 2019: 91 · 2018: 29
- FWCI
- 67.70
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RISalud Institutional Health Repository of Andalucía (submittedVersion, public-domain)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (submittedVersion, public-domain)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- eScholarship (California Digital Library) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion)
- Apollo
- Funders
- World Health Organization
- Leukemia and Lymphoma Society
- Wellcome Trust (WT 098051, WT095663MA)
- Cancer Research UK (23015, 14136, 16491, 21777)
- National Institute for Health and Care Research (NF-SI-0512-10114, NF-SI-0512-10135, NF-SI-0617-10149)
- Generalitat de Catalunya
- Associazione Italiana per la Ricerca sul Cancro
- Clalit Health Services
- Abisch-Frenkel-Stiftung
- Hellenic Health Foundation
- Medical Research Council (MC_UU_12015/1, MC_PC_13048, MC_PC_12009, MR/N003284/1)
- Agència de Gestió d'Ajuts Universitaris i de Recerca
- Instituto de Salud Carlos III (RD12/0036/0018)
- European Regional Development Fund
- National Cancer Institute (P30CA008748)
- Topics
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Keywords
- acute myeloid leukemia, somatic mutations, clonal expansion, variant allele frequency
- MeSH terms
- Adult, Age Factors, Aged, Female, Health, Humans, Male, Middle Aged, Models, Genetic, Mutation, Leukemia, Myeloid, Acute, Prevalence, Mutagenesis, Disease Progression, Risk Assessment, Genetic Predisposition to Disease, Electronic Health Records
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
